BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 29896193)

  • 1. Relapsing-Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment.
    Cunill V; Massot M; Clemente A; Calles C; Andreu V; Núñez V; López-Gómez A; Díaz RM; Jiménez MLR; Pons J; Vives-Bauzà C; Ferrer JM
    Front Immunol; 2018; 9():1097. PubMed ID: 29896193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.
    Wu Q; Wang Q; Mao G; Dowling CA; Lundy SK; Mao-Draayer Y
    J Immunol; 2017 Apr; 198(8):3069-3080. PubMed ID: 28258191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count.
    Longbrake EE; Cantoni C; Chahin S; Cignarella F; Cross AH; Piccio L
    Mult Scler; 2018 May; 24(6):728-738. PubMed ID: 28480794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular T Cells from smB
    Cunill V; Clemente A; Lanio N; Barceló C; Andreu V; Pons J; Ferrer JM
    Front Immunol; 2017; 8():174. PubMed ID: 28289412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice.
    Mehta D; Miller C; Arnold DL; Bame E; Bar-Or A; Gold R; Hanna J; Kappos L; Liu S; Matta A; Phillips JT; Robertson D; von Hehn CA; Campbell J; Spach K; Yang L; Fox RJ
    Neurology; 2019 Apr; 92(15):e1724-e1738. PubMed ID: 30918100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimethyl fumarate therapy suppresses B cell responses and follicular helper T cells in relapsing-remitting multiple sclerosis.
    Holm Hansen R; Højsgaard Chow H; Sellebjerg F; Rode von Essen M
    Mult Scler; 2019 Aug; 25(9):1289-1297. PubMed ID: 30043661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal response to dimethyl fumarate is mediated by a reduction of Th1-like Th17 cells after 3 months of treatment.
    Mansilla MJ; Navarro-Barriuso J; Presas-Rodríguez S; Teniente-Serra A; Quirant-Sánchez B; Ramo-Tello C; Martínez-Cáceres EM
    CNS Neurosci Ther; 2019 Sep; 25(9):995-1005. PubMed ID: 31066225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating T Follicular Helper Cell Abnormalities Associated to Different Clinical Forms of Chronic Chagas Disease.
    Quebrada Palacio LP; Fernández ER; Hernández-Vásquez Y; Petray PB; Postan M
    Front Cell Infect Microbiol; 2020; 10():126. PubMed ID: 32296649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis.
    Li R; Rezk A; Ghadiri M; Luessi F; Zipp F; Li H; Giacomini PS; Antel J; Bar-Or A
    J Immunol; 2017 Jan; 198(2):691-698. PubMed ID: 27974457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes.
    Carlström KE; Ewing E; Granqvist M; Gyllenberg A; Aeinehband S; Enoksson SL; Checa A; Badam TVS; Huang J; Gomez-Cabrero D; Gustafsson M; Al Nimer F; Wheelock CE; Kockum I; Olsson T; Jagodic M; Piehl F
    Nat Commun; 2019 Jul; 10(1):3081. PubMed ID: 31300673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethyl fumarate promotes B cell-mediated anti-inflammatory cytokine profile in B and T cells, and inhibits immune cell migration in patients with MS.
    Najjar E; Staun-Ram E; Volkowich A; Miller A
    J Neuroimmunol; 2020 Jun; 343():577230. PubMed ID: 32247228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.
    Longbrake EE; Ramsbottom MJ; Cantoni C; Ghezzi L; Cross AH; Piccio L
    Mult Scler; 2016 Jul; 22(8):1061-1070. PubMed ID: 26459150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of distinct subsets of circulating T follicular helper cells in Kawasaki disease.
    Xu M; Jiang Y; Wang J; Liu D; Wang S; Yi H; Yang S
    BMC Pediatr; 2019 Jan; 19(1):43. PubMed ID: 30704426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethyl fumarate therapy reduces memory T cells and the CNS migration potential in patients with multiple sclerosis.
    Holm Hansen R; Højsgaard Chow H; Christensen JR; Sellebjerg F; von Essen MR
    Mult Scler Relat Disord; 2020 Jan; 37():101451. PubMed ID: 31675639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutively altered frequencies of circulating follicullar helper T cell counterparts and their subsets in rheumatoid arthritis.
    Arroyo-Villa I; Bautista-Caro MB; Balsa A; Aguado-Acín P; Bonilla-Hernán MG; Plasencia C; Villalba A; Nuño L; Puig-Kröger A; Martín-Mola E; Miranda-Carús ME
    Arthritis Res Ther; 2014 Dec; 16(6):500. PubMed ID: 25475240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered distributions in circulating follicular helper and follicular regulatory T cells accountable for imbalanced cytokine production in multiple sclerosis.
    Haque R; Kim Y; Park K; Jang H; Kim SY; Lee H; Kim HJ
    Clin Exp Immunol; 2021 Jul; 205(1):75-88. PubMed ID: 33759187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional subsets of circulating follicular helper T cells in patients with atherosclerosis.
    Ghamar Talepoor A; Khosropanah S; Doroudchi M
    Physiol Rep; 2020 Nov; 8(22):e14637. PubMed ID: 33230950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.
    Fleischer V; Friedrich M; Rezk A; Bühler U; Witsch E; Uphaus T; Bittner S; Groppa S; Tackenberg B; Bar-Or A; Zipp F; Luessi F
    Mult Scler; 2018 Apr; 24(5):632-641. PubMed ID: 28436295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased frequencies of circulating follicular helper T cell counterparts and plasmablasts in ankylosing spondylitis patients Naïve for TNF blockers.
    Bautista-Caro MB; Arroyo-Villa I; Castillo-Gallego C; de Miguel E; Peiteado D; Plasencia-Rodríguez C; Villalba A; Sánchez-Mateos P; Puig-Kröger A; Martín-Mola E; Miranda-Carús ME
    PLoS One; 2014; 9(9):e107086. PubMed ID: 25203742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis.
    Yadav SK; Soin D; Ito K; Dhib-Jalbut S
    J Mol Med (Berl); 2019 Apr; 97(4):463-472. PubMed ID: 30820593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.